35.89
전일 마감가:
$36.19
열려 있는:
$36.78
하루 거래량:
2.11M
Relative Volume:
0.90
시가총액:
$4.49B
수익:
$1.12B
순이익/손실:
$5.00M
주가수익비율:
3,589.00
EPS:
0.01
순현금흐름:
$-383.00M
1주 성능:
+0.03%
1개월 성능:
+2.19%
6개월 성능:
+130.80%
1년 성능:
+189.44%
Indivior Plc Stock (INDV) Company Profile
명칭
Indivior Plc
전화
804-379-1090
주소
234 BATH ROAD, SLOUGH, BERKSHIRE
INDV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
INDV
Indivior Plc
|
35.89 | 4.52B | 1.12B | 5.00M | -383.00M | 0.01 |
|
ZTS
Zoetis Inc
|
125.67 | 57.00B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.90 | 49.88B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.05 | 45.73B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.40 | 36.84B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
RGC
Regencell Bioscience Holdings Ltd
|
52.88 | 16.33B | 0 | -5.87M | -767.30K | -0.45 |
Indivior Plc Stock (INDV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-06 | 개시 | H.C. Wainwright | Buy |
| 2025-07-22 | 재개 | Jefferies | Buy |
| 2025-01-28 | 개시 | Rodman & Renshaw | Buy |
| 2024-07-23 | 개시 | Piper Sandler | Overweight |
| 2024-04-03 | 개시 | Craig Hallum | Buy |
| 2023-07-13 | 개시 | Northland Capital | Outperform |
모두보기
Indivior Plc 주식(INDV)의 최신 뉴스
Insider Buying: Barbara Ryan Acquires Shares of Indivior PLC - GuruFocus
Ryan Barbara, Indivior director, buys $27,429 in shares By Investing.com - Investing.com UK
Indivior director Ninivaggi buys $27,429 in shares By Investing.com - Investing.com South Africa
Wheadon David E., Indivior director, buys $62,680 in shares By Investing.com - Investing.com UK
Humphreys Keith buys Indivior (INDV) shares worth $27,429 - Investing.com
Indivior director Stejbach buys $27,429 in shares By Investing.com - Investing.com India
Humphreys Keith buys Indivior (INDV) shares worth $27,429 By Investing.com - Investing.com UK
Ryan Barbara, Indivior director, buys $27,429 in shares - Investing.com
Wheadon David E., Indivior director, buys $62,680 in shares - Investing.com
Will Indivior PLC stock reach all time highs in 20252026 world cup usa national team quarterfinals defensive leaders low block defense match prediction insights - ulpravda.ru
New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations - Eastern Progress
This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table - AOL.com
Indivior outlines $1.03B–$1.08B 2025 revenue guidance and cost structure overhaul through action agenda - MSN
Suboxone Market is Going to Booming Growth 2025 With Top Key - openPR.com
Indivior PLC stock: volatile swings, legal overhangs and a nervous market mood - AD HOC NEWS
(INDV) Risk Channels and Responsive Allocation - Stock Traders Daily
Aug Opening: How Indivior PLC 2IVB stock responds to job market shiftsPortfolio Return Summary & Target Return Focused Stock Picks - moha.gov.vn
Daily Penny AlertsIndivior PLCOrdinary Shares (Nasdaq:INDV) Stock Quote - FinancialContent
Indivior PLC: Opioid-treatment specialist tests investor nerves as volatility returns - AD HOC NEWS
Indivior PLC (INDV) Stock Price History & Data - Traders Union
What’s next for Indivior after a 200% run? Jefferies eyes 2026 upside - Investing.com
Indivior (NasdaqGS:INDV): Revisiting Valuation After S&P SmallCap 600 Inclusion and Strong Recent Share Price Gains - Yahoo Finance
Does S&P SmallCap 600 Inclusion Refocus Indivior’s (INDV) Story Around Its SUBLOCADE Franchise? - Yahoo Finance
Is It Too Late To Consider Indivior After Its 191.6% Surge In 2025? - Yahoo Finance
Indivior Announces Inclusion in the S&P SmallCap 600® Index - Sahm
Dividend Watch: What margin trends mean for Indivior PLC stockJuly 2025 WrapUp & Growth Focused Stock Reports - moha.gov.vn
Indivior Joins S&P SmallCap 600 Index - marketscreener.com
Indivior Added to S&P SmallCap 600, Enhancing Visibility - TipRanks
Indivior PLC Announces Inclusion in S&P SmallCap 600 Index - TradingView — Track All Markets
Published on: 2025-12-22 18:20:56 - moha.gov.vn
Indivior PLC(NasdaqGS: INDV) added to S&P 1000 - marketscreener.com
Indivior PLC(NasdaqGS: INDV) added to S&P 600 - marketscreener.com
(INDV) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Indivior (NasdaqGS:INDV): Reassessing Valuation After Positive SUBLOCADE and INDV-2000 Clinical Trial Results - Sahm
Aug Swings: What Wall Street predicts for Indivior PLC stock priceJuly 2025 Breakouts & Verified Momentum Watchlists - Улправда
What Wall Street predicts for Indivior PLC stock priceWeekly Gains Report & Technical Confirmation Trade Alerts - Улправда
Earnings Update: How Indivior PLC stock performs in high volatility markets2025 Major Catalysts & High Accuracy Swing Entry Alerts - Улправда
Why hedge funds are buying Indivior PLC stock2025 Key Highlights & High Win Rate Trade Alerts - DonanımHaber
Indivior approves executive salary increases for senior leadership - TipRanks
Indivior Shareholders Approve Scheme of Arrangement - TipRanks
The Bull Case For Indivior (INDV) Could Change Following New SUBLOCADE Fentanyl-User Efficacy Data - simplywall.st
Extended-release buprenorphine shows efficacy in opioid use disorder By Investing.com - Investing.com Nigeria
Indivior (INDV) Trial Shows Potential of SUBLOCADE in Reducing O - GuruFocus
Extended-release buprenorphine shows efficacy in opioid use disorder - Investing.com
Indivior’s INDV-2000 Study Completion: A Potential Game-Changer for Opioid Use Disorder - TipRanks
Indivior (INDV) Is Up 8.9% After Newtyn Ups Stake And EBITDA Guidance RisesHas The Bull Case Changed? - Sahm
Indivior stock hits all-time high at 37.72 USD By Investing.com - Investing.com Canada
What drives Indivior PLC stock priceWeekly Market Snapshot & Double Or Triple Profits - earlytimes.in
Indivior stock hits all-time high at 37.72 USD - Investing.com
Indivior Plc (INDV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):